About Rampex Labs
Rampex Labs is a company based in Hyderabad (India) founded in 2004. Rampex Labs has raised $2.73 million across 3 funding rounds from investors including Krishnapolypacks, Madhavi Gorrepati and Pallavi Gorrepati. The company has 322 employees as of April 02, 2024. Rampex Labs offers products and services including Advanced Intermediates and APIs.
- Headquarter Hyderabad, India
- Employees 322 as on 02 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rampex Labs Private Limited
- Date of Incorporation 18 May, 2004
- Jurisdiction Bollaram Villege, Telangana, India
-
Annual Revenue
$16.47 M (USD)4.76as on Mar 31, 2023
-
Net Profit
$50.38 K (USD)-56.73as on Mar 31, 2023
-
EBITDA
$1.18 M (USD)-5.93as on Mar 31, 2023
-
Total Equity Funding
$2.73 M (USD)
in 3 rounds
-
Latest Funding Round
$2.09 M (USD), Series A
May 15, 2018
-
Investors
Krishnapolypacks
& 6 more
-
Employee Count
322
as on Apr 02, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rampex Labs
Rampex Labs offers a comprehensive portfolio of products and services, including Advanced Intermediates and APIs.
Advanced intermediates are developed and manufactured for pharmaceutical applications
APIs are produced through custom synthesis for various pharmaceutical uses
Funding Insights of Rampex Labs
Rampex Labs has successfully raised a total of $2.73M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.09 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $2.1M
-
First Round
First Round
(14 Sep 2014)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Series A - Rampex Labs | Valuation |
investors |
|
| Apr, 2017 | Amount | Seed - Rampex Labs | Valuation |
investors |
|
| Sep, 2014 | Amount | Seed - Rampex Labs | Valuation |
investors |
Investors in Rampex Labs
Rampex Labs has secured backing from 7 investors, including institutional and angel investors. Prominent investors backing the company include Krishnapolypacks, Madhavi Gorrepati and Pallavi Gorrepati.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Espee Group is engaged in clinical trials and bioequivalence studies support.
|
Founded Year | Domain | Location | |
|
MG
Madhavi Gorrepati |
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rampex Labs
Financial Statements - Rampex Labs
Rampex Labs Comparisons
Competitors of Rampex Labs
Latest news on Rampex Labs
Frequently Asked Questions about Rampex Labs
Rampex Labs was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Rampex Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Rampex Labs is a funded company, having raised a total of $2.73M across 3 funding rounds to date. The company's 1st funding round was a Seed of $343.92K, raised on Sep 14, 2014.
As of Apr 02, 2024, the latest employee count at Rampex Labs is 322.
Annual revenue of Rampex Labs is $16.47M as on Mar 31, 2023.
Rampex Labs Pvt. Ltd. was founded in 2004 and is based in Hyderabad, India. Intermediates for active pharmaceutical ingredients (APIs) compliant with various pharmacopoeias are produced by the company in the pharmaceutical sector. Operations are conducted across two manufacturing plants, with one approved by the USFDA. A dedicated RD center is maintained, and investments have been made in effluent handling equipment to support environmental sustainability.
Rampex Labs offers Advanced Intermediates and APIs.
Rampex Labs has 7 investors. Key investors include Krishnapolypacks, Madhavi Gorrepati, Pallavi Gorrepati, Ranga Gorrepati, and Espee Group.
The valuation of Rampex Labs is $13.11M as of May 2018.